Biotech Lock-Up Expiration Hell Portfolio Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (182)	6/25/2001 12:47:56 PM
From: tuck	of 1005

Where will MCLS' run end? It's just a chemistry company, but with the FDA hostile and pharmas not buying equipment, maybe that's a good thing. It is obviously getting some big money support. It has announced some news, and could have another deal or two up its sleeve. But I am wondering if the next deal will come soon enough to provide the boost needed to get through what I see as the first substantial resistance in the high 4s: siliconinvestor.com For now, BLUE HP intends to cash in its MCLS chips at $4.50. Should it keep going, BLUE HP and Trickle will wave goodbye. If it does retrace, both will say hello in the 2s and 3s. 2nd and 3rd place? PBSC and AGNT. The Tool Companies are Dead! Long Live the Tool Companies! Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next